vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $66.0M, roughly 1.7× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -1.6%, a 41.0% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $42.0M).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

ILPT vs SLNO — Head-to-Head

Bigger by revenue
ILPT
ILPT
1.7× larger
ILPT
$113.9M
$66.0M
SLNO
Higher net margin
SLNO
SLNO
41.0% more per $
SLNO
39.4%
-1.6%
ILPT
More free cash flow
SLNO
SLNO
$1.4M more FCF
SLNO
$43.5M
$42.0M
ILPT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ILPT
ILPT
SLNO
SLNO
Revenue
$113.9M
$66.0M
Net Profit
$-1.8M
$26.0M
Gross Margin
98.3%
Operating Margin
-22.1%
33.5%
Net Margin
-1.6%
39.4%
Revenue YoY
3.1%
Net Profit YoY
92.6%
134.0%
EPS (diluted)
$-0.02
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
SLNO
SLNO
Q4 25
$113.9M
Q3 25
$110.9M
$66.0M
Q2 25
$112.1M
$32.7M
Q1 25
$111.9M
Q4 24
$110.5M
Q3 24
$108.9M
Q2 24
$110.6M
Q1 24
$112.2M
Net Profit
ILPT
ILPT
SLNO
SLNO
Q4 25
$-1.8M
Q3 25
$-21.6M
$26.0M
Q2 25
$-21.3M
$-4.7M
Q1 25
$-21.5M
Q4 24
$-24.1M
Q3 24
$-25.0M
Q2 24
$-23.2M
Q1 24
$-23.4M
Gross Margin
ILPT
ILPT
SLNO
SLNO
Q4 25
Q3 25
98.3%
Q2 25
97.9%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ILPT
ILPT
SLNO
SLNO
Q4 25
-22.1%
Q3 25
-29.4%
33.5%
Q2 25
-30.8%
-20.0%
Q1 25
-26.9%
Q4 24
-31.1%
Q3 24
-33.5%
Q2 24
-32.4%
Q1 24
-31.7%
Net Margin
ILPT
ILPT
SLNO
SLNO
Q4 25
-1.6%
Q3 25
-19.4%
39.4%
Q2 25
-19.0%
-14.4%
Q1 25
-19.2%
Q4 24
-21.8%
Q3 24
-22.9%
Q2 24
-20.9%
Q1 24
-20.9%
EPS (diluted)
ILPT
ILPT
SLNO
SLNO
Q4 25
$-0.02
Q3 25
$-0.33
$0.47
Q2 25
$-0.32
$-0.09
Q1 25
$-0.33
Q4 24
$-0.37
Q3 24
$-0.38
Q2 24
$-0.35
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$94.8M
$498.9M
Total DebtLower is stronger
$4.2B
Stockholders' EquityBook value
$489.7M
$494.8M
Total Assets
$5.2B
$599.9M
Debt / EquityLower = less leverage
8.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
SLNO
SLNO
Q4 25
$94.8M
Q3 25
$83.2M
$498.9M
Q2 25
$58.6M
$286.8M
Q1 25
$108.0M
Q4 24
$131.7M
Q3 24
$153.9M
Q2 24
$146.2M
Q1 24
$128.4M
Total Debt
ILPT
ILPT
SLNO
SLNO
Q4 25
$4.2B
Q3 25
$4.2B
Q2 25
$4.2B
Q1 25
$4.3B
Q4 24
$4.3B
Q3 24
$4.3B
Q2 24
$4.3B
Q1 24
$4.3B
Stockholders' Equity
ILPT
ILPT
SLNO
SLNO
Q4 25
$489.7M
Q3 25
$494.1M
$494.8M
Q2 25
$519.1M
$240.1M
Q1 25
$539.5M
Q4 24
$562.0M
Q3 24
$585.9M
Q2 24
$618.3M
Q1 24
$643.2M
Total Assets
ILPT
ILPT
SLNO
SLNO
Q4 25
$5.2B
Q3 25
$5.2B
$599.9M
Q2 25
$5.2B
$332.3M
Q1 25
$5.4B
Q4 24
$5.4B
Q3 24
$5.5B
Q2 24
$5.5B
Q1 24
$5.5B
Debt / Equity
ILPT
ILPT
SLNO
SLNO
Q4 25
8.56×
Q3 25
8.49×
Q2 25
8.09×
Q1 25
7.96×
Q4 24
7.65×
Q3 24
7.35×
Q2 24
6.96×
Q1 24
6.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
SLNO
SLNO
Operating Cash FlowLast quarter
$60.7M
$43.5M
Free Cash FlowOCF − Capex
$42.0M
$43.5M
FCF MarginFCF / Revenue
36.9%
65.8%
Capex IntensityCapex / Revenue
16.4%
0.0%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$79.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
SLNO
SLNO
Q4 25
$60.7M
Q3 25
$22.7M
$43.5M
Q2 25
$18.4M
$-12.6M
Q1 25
$11.4M
Q4 24
$2.0M
Q3 24
$-3.4M
Q2 24
$10.8M
Q1 24
$8.0M
Free Cash Flow
ILPT
ILPT
SLNO
SLNO
Q4 25
$42.0M
Q3 25
$17.6M
$43.5M
Q2 25
$15.2M
$-12.6M
Q1 25
$5.0M
Q4 24
$-3.7M
Q3 24
$-5.9M
Q2 24
$9.4M
Q1 24
$5.9M
FCF Margin
ILPT
ILPT
SLNO
SLNO
Q4 25
36.9%
Q3 25
15.9%
65.8%
Q2 25
13.5%
-38.6%
Q1 25
4.5%
Q4 24
-3.4%
Q3 24
-5.5%
Q2 24
8.5%
Q1 24
5.2%
Capex Intensity
ILPT
ILPT
SLNO
SLNO
Q4 25
16.4%
Q3 25
4.6%
0.0%
Q2 25
2.9%
0.0%
Q1 25
5.7%
Q4 24
5.2%
Q3 24
2.3%
Q2 24
1.3%
Q1 24
1.9%
Cash Conversion
ILPT
ILPT
SLNO
SLNO
Q4 25
Q3 25
1.67×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons